Since 1902, animals have been studied and occasionally used as sources of organs for transplantation, usually when human organs were unavailable. Clinical organ xenotransplantation invariably failed, whereas clinical organ allotransplantation rose to become a primary treatment for failure of the heart, kidneys, liver, and lungs. Still, a shortage of human organs has limited organ transplantation and motivates ongoing efforts to advance xenotransplantation into clinical practice. Griffith and colleagues1 now report in the Journal the transplantation of a heart from a pig into a patient who had severe cardiac failure. The pig was genetically engineered to disrupt certain genes, including those . . .
Funding and Disclosures
Disclosure forms provided by the authors are available with the full text of this editorial at NEJM.org.
This editorial was published on June 22, 2022, at NEJM.org.
Print Subscriber? Activate your online access.